The University of Surrey has appointed Devereux Architects to create a masterplan for its new School of Veterinary Medicine.
As one of the University's largest and most prestigious future development sites, the new school, which sits within the Faculty of Health and Medical Sciences, will comprise three complimentary and inter-related buildings totalling approximately 9000m2 - an Academic Building, a Veterinary Clinical Skills Centre and a Veterinary Pathology Facility.
The new building will be positioned at the corner of the new campus green at Manor Park. It will feature naturally ventilated office and teaching spaces along one side of the atrium and research spaces and lecture halls along the other. The roof of the atrium is shaped to guide rising, warmed air into the plant room where the heat can be extracted and reused.
The new academic building will provide world-class teaching and research laboratories, lecture theatres, and flexible break out spaces organised around a common shared atrium.
Professor Lisa Roberts, Dean of the Faculty of Health and Medical Sciences, said: "We were very impressed with the design concept for the new School of Veterinary Medicine that Devereux Architects presented at the tendering stage. We are looking forward to working with the professional team at Devereux Architects to deliver this major project for the University of Surrey."
Fashion website Lyst caused a bit of a storm amongst pet lovers on the twitosphere this week after announcing the 'launch' of The Canine Collection, a range of puppies sold as accessories to the company's range of fashion clothing.
The Canine Collection was described as comprising 33 different dog breeds, 'from petite XS puppies to oversized companions, in a choice of six wearable colourways'. Visitors to the site were invited to: 'Find the right dog to match your wardrobe from our curated selection of breeds that are as stylish as they are lovable'.
Whilst the launch was obviously a PR stunt (after selecting what size you wanted your new dog in, pressing 'buy' just sent an email), some people were obviously taken in, branding the collection 'DISGUSTING', 'despicable' and 'sick' on Twitter.
Later in the day, the RSPCA stepped in, telling the MirrorOnline: "Whether this is real or just a publicity stunt by Lyst, it sends out an extremely worrying message to people who are looking to get a new canine companion… We have tried to make contact with Lyst to discuss with them the implications a stunt like this might have."
Lyst's website has now been updated with the message: "Of course you can't buy puppies and dogs here, we sell clothes not canines. But unfortunately, thousands of puppies and dogs are bought and abandoned every year. According to Blue Cross, the number of small "handbag" dogs and puppies needing to be re-homed has increased by 120% in the last five years, with "fashionable" toy dog breeds in particular being given up in record numbers. A dog is for life, not just for Instagram."
Whether that was added hastily in response to the reaction, or planned all along, is unclear. Either way, Lyst points out that the number of people talking about puppy farming on Twitter last week was 158, compared to 10,000+ pet owners expressing outrage at the idea of puppies as fashion accessories in just 2 days. So perhaps some good has come of it all.
The Brexit Barometer report draws on insights from 16 animal medicines companies and other stakeholders. 95% of those who contributed to the report, drawn up after NOAH’s Brexit event in May, said that they are optimistic about the future of animal health and welfare in the UK.
On the broader future of the industry, contributors to the report were more uncertain: 40% 'in the middle', 30% 'optimistic' and 25% 'pessimistic'. In contrast to animal welfare, contributors were most pessimistic about the future of trade and exports in relation to animal health.
While optimism about animal welfare remains high, NOAH says the animal medicines industry needs a continuation of its high standards of health and welfare to help tackle antibiotic resistance and to put the UK in a strong influencing position with our ability to trade. Six key measures in relation to health and welfare that Government needs to take to realise the opportunities were outlined in the report. They are:
• Maintaining the current Animal Welfare Acts and evolving them to secure the UK’s position from ‘Day 0’• Ensuring the industry is not disadvantaged by lack of veterinary medicines availability during the transition period and beyond, as new products come on the market• Ensuring that veterinary services are available in inner city and rural areas throughout the UK• Ensuring that a cross-border programme is in place to maintain cooperation between the UK and Europe• Recognising that animal diseases do not respect borders and to co-operate with our European neighbours to ensure that appropriate measures are in place to prevent and control disease outbreaks• Balancing first-class welfare standards with creating a level playing field for UK farmers and ensuring that British product does not become uncompetitive.
NOAH Chief Executive, Dawn Howard said: "While the Barometer showed that a large proportion of the industry was undecided when it comes to overall future of our sector, it tells us loudly and clearly that the sector sees a very clear opportunity for the UK to show leadership when it comes to animal health and welfare. What is vital now is that Government collaborates closely with industry and heeds its advice to realise this opportunity and leverage these high levels of optimism. We must not forget that veterinary medicines support the health and welfare of the UK’s livestock and pets and we stand ready to work with industry and Government to help make this happen."
BVA President Gudrun Ravetz said: "We have a unique selling point as 'UK PLC' around our high standards of animal welfare and food safety and these must be maintained in the wake of Brexit. This means tackling issues including veterinary involvement from farm to fork to underpin animal health, welfare and public health, through to guaranteeing working rights for vets and veterinary nurses. It is therefore vital that animal welfare is included in all trade negotiations."
The report can be read in full here: https://www.noah.co.uk/wp-content/uploads/2017/07/NOAH-Brexit-Barometer-Summer-17-6pp-A4-vf.pdf
The International Society of Feline Medicine (ISFM) has published 'Consensus Guidelines on the Long-term use of NSAIDs in cats' in the July 2010 edition of the Journal of Feline Medicine and Surgery.
The society says it has developed the guidelines in order to try and address the major welfare issue of cats suffering unremitting and untreated chronic pain. Until recently, NSAIDs had only been licensed for short-term use in cats, but with changing licensing indications and recommendations, they are now also increasingly used for long-term treatment of cats, for example in the management of osteoarthritis.
However, in most cases where long-term use of pain relief in cats is required, there are concomitant problems with other diseases or other drugs that are being given. According to the ISFM, one of the most common concerns is whether NSAIDs can be used to treat arthritis in older cats with kidney disease. The society says that because of concerns like these, and the potential for adverse effects, cats often receive no treatment at all, and their quality of life can be severely compromised.
For this reason, the ISFM set up an international expert panel to develop practical and rational guidelines on the long-term use of NSAIDs in cats. The aim was to provide guidelines that would empower clinicians, enabling them to make sensible and rational choices, and ensure much-needed therapy is not needlessly withheld from patients.
The panel was made up of Andrew Sparkes, Duncan Lascelles, Richard Malik, Sheilah Robertson, Margie Scherk, Polly Taylor, Llibertat Real Sampietro and Reidun Heiene.
Along with the veterinary information in the guidelines, the panel also developed a brief client-facing leaflet that can be given to owners when NSAIDs are prescribed for their cats - this leaflet provides simple, clear advice on why NSAIDs are used, why they are important, but also what simple precautions avoid adverse effects, with further advice on when to seek veterinary advice to reinforce the safety message.
Both of these publications are available to download from the website www.isfm.net/toolbox
The Royal Veterinary College is calling for dogs diagnosed with osteoarthritis to take part in a revolutionary study in which their movement will be monitored by a state-of-the-art recorder.
The recorder (pictured right), which is attached to the dog's collar, uses miniaturised sensors based on those found in smart phones. It can distinguish between different activities independent of the dog's location, allowing constant recording of movement in the dog's home environment, to complement the traditional clinical assessments carried out as part of the trial.
The study is being carried out to assess the efficacy of the joint mobility supplement Yumove in reducing the clinical signs of osteoarthritis. This will be the first time that the real effect of a joint supplement has been measured.
Dr. John Howie, co-founder of Lintbells, the company that makes Yumove, said: "This is the first time the real effect of a joint supplement has been measured and it will be a very fast trial. Yumove is a supplement that has been specifically formulated to include glucosamine, chondroitin and Omega 3 from green-lipped mussel, which all work together to increase joint mobility and provide an anti-inflammatory effect."
The research is being led by Dr Matthew Pead the RVC's Academic Director of Professional Assessment and Development. He said: "The results of this study will have important clinical implications for the understanding and treatment of canine OA, with the ultimate aim of advancing the treatment of this difficult and degenerative disease for the benefit of many thousands of dogs."
Any veterinary surgeon with a patient in their practice that might benefit from this study is invited to refer them. Further details are available the Clinical Investigation Centre at the Royal Veterinary College - email cic@rvc.ac.uk or phone 01707 666605.
A new device call the Animalarm, which sends dog owners an SMS text message if the temperature in their car exceeds a preset threshold, has been launched this week.
Apparently, you can also ring the device to check what the temperature is inside your car.
The Animalarm sells for £108 inc. VAT from www.animalarm.co.uk.
Now all we need is a bit of sun.
Scrubs Etc Limited has announced the launch of Steribond, a new skin adhesive notable for the fact that it is sterile and can be stored at ambient temperature for up to 18 months.
The product has so far only been launched to a limited number of people at the London Vet Show last November.
According to the company, Steribond is as strong as a 3.0 suture for external sutures and can therefore be used in place of sutures and staples. It has a 10 second setting time, and will stay in place for between 5 to 10 days, depending on the site of injury and other factors.
The product has a precision applicator with a transparent reservoir, allowing the user to see how much adhesive is available and that the applicator is primed. The company says that it allows for a cosmetically neater wound closure, which can be important to customers. In addition, it is a no-sting product which Scrubs Etc says can remove the need to sedate the animal in come circumstances, thereby reducing costs. Steribond is also showerproof.
Steribond is currently on special offer, priced at £83.64 (usual price £102.00 incl. VAT).
For more information, contact Scrubs Etc Ltd on 0870 080 2332 or see: http://www.scrubsuk.com/steribond-veterinary-skin-adhesive-box-of-10-devices.html
To date most of these imaging procedures have been performed by vets within the group’s small animal first opinion veterinary practices.
The company says its Foundations in Diagnostic Imaging for Nurses training is designed to give its nurses more clinical stature in first opinion practice.
The programme will teach nurses the workings of an x-ray machine, common X-ray positions and contrast material.
It will also cover the principles of CT and MRI, showing how to set up and operate each piece of equipment, and how to support patients through these imaging procedures.
Finally, the course will provide the training nurses need to be able to perform ultrasounds within the current RCVS legal frameworks.
CVS says it believes this is a first in the veterinary profession
Tara Ryan, Chief Veterinary Nursing Officer at CVS said: “Imaging is a brand new area that we are starting to delegate to our nurses.
"Having heavily invested in our small animal first opinion practices over the last decade, we have a wide range of imaging equipment at many of our sites.
“Excitingly, this programme will open up the ability for nurses to start to contribute more information - to help vets identify and diagnose conditions and diseases in patients.
"It is another big step that we are taking to empower our brilliant nurses and to enable them to make a great clinical contribution towards the care of our patients – and to be the nurses they want to be.”
CVS is prioritising the consulting room and Schedule 3 delegated tasks as important areas for improving what it calls 'nurse optimisation'.
The company recognises that 'buy in' from veterinary surgeons is vital to the success of its efforts to optimise the role of its nurses, and the group has also published guidelines to provide clarity around effective delegation under Schedule 3.
Merial has released the results of a survey - carried out in conjunction with VetSurgeon.org - into the use of nutraceuticals for the management of canine joint problems.
The company says the total market for nutraceutical products remains strong, holding a value of £8.9 million* in the UK, and that this indicates that despite increasing economic pressures, nutraceuticals are still valued by veterinary surgeons and owners as an important part of the management approach to canine joint disease.
The survey generated 163 responses. Results showed that whilst 58% of canine patients with joint health problems received only NSAIDs for treatment, 28% of patients received both NSAIDs and a joint health nutraceutical and 14% received a nutraceutical alone, demonstrating the importance that veterinary practitioners place on the use of nutraceuticals. The survey also showed that on average, UK vets stock and recommend at least two nutraceutical products.
Supleneo flex Product Manager Claire Edmunds said: “This eshot survey yielded some interesting results and the email received the second highest recorded opening rate this year, indicating that it is a topic of great interest. The survey confirmed that vets are actively recommending nutraceuticals, alongside NSAIDs, for canine patients with joint health problems. These data also show that the market remains stable as the level of dispensing correlates well with our previous research. To encourage even more growth in this sector and support the launch of Supleneo flex we have produced a range of support materials, including the provision of samples, money off next purchase vouchers and a loyalty programme. In this way we can continue to support vets in their management of canine joint problems.”
For more information call Merial on 0870 6000 123 or contact your Territory Manager.
Rabbit Viral Haemorrhagic Disease variant (RVHD2) is a variation of the already recognised Rabbit Viral Haemorrhagic Disease (RVHD1). Vaccines for the original strain of RVHD do not appear to offer long term protection against RVHD2, however vaccines for this new strain are now available in the UK and can be purchased through three UK wholesalers (NVS, Centaur and Henry Schein Animal Health) or direct from the suppliers in Europe. There have been supply issues with this vaccination, however these are hoping to be remedied soon.
RVHD2 is more variable in its rate of disease progression than RVHD1, with presentation ranging from sudden death (with or without bleeding from the orifices), to a longer disease course of three to nine days, increasing the risk of unwell rabbits being brought into practices and in turn increasing the risk of transmission to other pet rabbits. Until vaccination becomes more routine, biosecurity in practices is key to prevent the disease from spreading.
Sean Wensley, BVA President, said: "Although the risk of a rabbit contracting RVHD2 appears highest in situations where rabbits are kept in large groups with regular new additions, such as at breeders or rescue centres, we encourage all owners to speak to their vet about vaccinating their rabbits against RVHD2.
"Veterinary advice from The Rabbit Welfare Association and Fund (RWAF) has stated that the spread of RVHD2 may be facilitated by its apparent slower disease progression compared to RVHD1, and research suggests that we can expect to see RVHD2 starting to predominate in the UK’s wild rabbits over RVHD1 in the next five years or so."
John Chitty, BSAVA Vice President, said: "BSAVA would encourage practices to talk to rabbit owning clients about RVHD2 vaccines, and where there is deemed sufficient risk recommend the vaccine along with the essential vaccination against Myxomatosis – and it should be noted that this must not be done within two weeks of vaccination against RVHD2."
BVZS President and veterinary pathologist Mark Stidworthy said: "It is clear from post mortem examinations and PCR testing over the last 18 months that RVHD2 is now geographically widespread in the UK and all rabbits should be considered at risk from this potentially devastating disease."
Due to recent media coverage of RVHD2, vets may be contacted by concerned owners seeking advice on how to prevent their rabbits contracting this disease - further to vaccinating, vets should recommend rabbits are kept separate from any other rabbits they do not usually interact with; are prevented from having contact with wild rabbits and do not attend any rabbit shows unless already vaccinated.
For a detailed Q&A on RVHD2 from Richard Saunders MRCVS, veterinary advisor to the RWAF, including information on sourcing effective vaccines, visit www.rabbitwelfare.co.uk and click RVHD2 - Filavac Vaccine – FAQs on the home page.
Photo: Larry D. Moore CC BY-SA 3.0.
Procanicare contains three canine-specific strains of Lactobacillus bacteria, which the company says are proven to improve stool consistency, accelerate recovery following acute episodes of diarrhoea and improve well-being.1
The company also points to a number of studies which it says are evidence of the importance of supporting puppies' intestinal microbiomes.
'New puppy diarrhoea' is, it says, typically due to exposure to factors that are known to risk microbiome disturbance, such as diet change and going to a new home, at a time when the microbial population is at its more sensitive.2
Animalcare says other studies show that microbiome disturbances in early life can have a significant impact on health in adulthood.2,3
James Beaumont, Marketing Manager at Animalcare said: “We often hear from breeders, new puppy owners and vets that puppies which have had Procanicare seem brighter, have firmer stools and less flatulence. With the evidence mounting that the adult intestinal microbiome is shaped in early life and knowing the important and varied role that it has in wider health throughout life, we want to help vets proactively support the GI health of their youngest patients by providing Procanicare for them to trial, with no risk.”
References
The guide, which was first published in 2020, is designed to help veterinary professionals give pet owners sound, independent advice about what to feed their animals.
The guide originally launched with factsheets for both veterinary professionals and pet owners about commercially manufactured, grain-free, raw and home-prepared cooked diets.
The new factsheets cover:
The new factsheets build on considerations for feeding healthy dogs and cats by providing information on the formulation of diet types for pets under veterinary care and those with even more specific nutritional requirements.
The new BSAVA Guide to Nutrition cost £40, reduced to £26 for BSAVA members from: https://www.bsavalibrary.com/
Speakers include Dr Ian Stroud, founder and veterinary director of Pet People, an independent small animal practice in Richmond, South West London, Jack Peploe, a veterinary IT expert and Certified Ethical Hacker, and Ciaran Milford, ezyVet’s EMEA sales manager, who has worked with every type of veterinary practice, from aspiring independents right through to established universities and corporate groups.
Lance Rice, creative director at ezyVet, who will moderate the webinar, said: “This webinar is for anyone who feels as though they’ve gone as far as they can in a senior vet or clinic director role, and thinks it might be time to follow their dream of opening their own practice.
“Our speakers are all vastly experienced and ideally positioned to explain what makes a successful launch, as well as the key mistakes and common traps that new owners fall into.
"Ian has a unique understanding of the challenges and opportunities involved with starting a veterinary practice.
"Jack is an expert in helping practices leverage technology to save time, whilst delivering exceptional patient care and bolstering their security posture.
"Ciaran is passionate about helping practices find the right solutions for their needs and business goals."
To register, visit: https://www.ezyvet.com/webinar/starting-a-vet-practice-uk
MSD Animal Health has launched a new Chronogest CR pack for practices starting a dialogue with sheep producer clients about planned breeding for 2013 lamb sales, and is offering a free applicator with every four packs purchased.
The Chronogest CR intra-vaginal sponges, impregnated with 20mg of cronolone (flugestone acetate) synthetic hormone, are now available in foil wrapped packs of 25. The packs protect the sponges from light and moisture.
MSD is reminding practitioners that sponging programmes must be planned at least six weeks in advance of mating, with PMSG-Intervet injections essential at sponge removal.
The new packs of 25 will be available when existing 25, 50 and 100 pack sizes sell out.
Further information on planned breeding - including newsletter copy and sheep producer advisory materials - is available from the MSD Animal Health veterinary support group (VSG) on 01908 685685 or via emailing vet-support.uk@merck.com
Ceva Animal Health has produced a new advisory leaflet about enzootic abortion control and vaccination strategy in sheep to help vets explain the best prevention protocols to clients.
According to the company, it is estimated that around half of the 400,000 infectious abortions in UK sheep each year are from enzootic abortion caused by Chlamydophila abortus, but timely vaccination programmes can prevent such dramatic losses.
The eight-page leaflet explains how enzootic abortion can spread, why prevention is better than cure, the importance of timely vaccination of ewe lambs and replacement stock, how vaccination programmes make good economic sense and the benefits of using Cevac Chlamydia, Ceva Animal Health's live enzootic abortion vaccine as part of the control programme.
Carol Atkinson, reprodAction's product manager said: "Cevac Chlamydia receives consistently good feedback from vets, many of whom have enthusiastically volunteered their praise for the product to our territory managers. We thought a leaflet would be a constructive way to share views, giving vets the chance to hear about the advantages of vaccination and to provide them with the tools to explain to their clients why vaccinating against enzootic abortion is cost worthy."
For further information contact Ceva Animal Health Ltd, Unit 3, Anglo Office Park, White Lion Road, Amersham, Bucks, HP7 9FB, Telephone +44 (0) 1494 781510.
Veterinary scientist, Dr Alex German and veterinary nurse, Shelley Holden are joining presenter and vet, Mark Evans in a new Channel Four series exploring the secret life of dogs, the first of which airs tonight at 8:00pm.
The three-part series looks at how people's lives and those of their dogs have radically changed in the last 50 years.
Using hidden cameras, episode one investigates how dogs gain weight when their owners are not present or out at work, as well as what research is being done to understand the UK's obesity epidemic in dogs and cats.
Alex, who is head of the University's Weight Management Clinic, said: "Obesity is common in dogs and can lead to a range of illnesses and diseases.
"Although treatment for weight loss has been in existence for some time it has not been without its problems, and owners, with busy lives, can find it difficult to even understand how their dog has gained weight in the first place.
"By showing what dogs get up to out of their owner's sight, this programme explores how understanding our animals' behaviour and habits can help in producing a healthy diet and exercise regime."
Dr German has also contributed to the Channel Four website, which provides information for owners and access to case studies: http://dogs.channel4.com/fat-dogs/
During a welcome reception, leaders and representatives of the veterinary profession were given tours of the facility and shown the advanced surgical training and ultrasound equipment available.
The wet-lab is equipped with 13 electrically-adjustable surgical tables, each with their own operating light and an audio-visual (a/v) system connecting them to the lecturer. The a/v system enables the lecturer to carry out demonstrations of procedures and to provide individual or group guidance to delegates practising surgical and other practical techniques.
Delegates are able to use the latest surgical and diagnostic equipment, including IM3 dental equipment, Logic E ultrasound machines and new surgical instrumentation for a range of orthopaedic and soft tissue procedures.
Improve's Managing Director, David Babington MRCVS, said: "Newly qualified vets have a huge need for additional training in practical skills and this demand extends into their ongoing professional life as new techniques are developed and existing ones refined.
"We already offer practical training facilities to delegates attending our training programmes at our HQ in Swindon but wanted to make it easier for vets and nurses in the north of the UK to access these facilities. This new 'wet-lab' offers an ideal training environment for our delegates to accelerate their learning and take new skills back to their practice."
He added: "Learning new techniques, whether surgical or diagnostic, is a proven way to boost practice profitability because it reduces the need to refer more complex cases. We hear from many of those who have trained with us that their increased skillset has enhanced their job satisfaction and increased the volume of cases they treat. In many cases, the training has paid for itself many times over. We are excited at the prospect of helping even more veterinary professionals to advance their skills."
Time is running out to nominate your fellow staff members for this year's 'Petplan Pet Insurance Advisor Award'.
The award recognises the hard work and dedication that Pet Insurance Advisors (PIAs) do to highlight the importance of insurance to pet owners so that they are protected financially.
Donna Lewis, President of The British Veterinary Nursing Association said: "The PIA in a practice is an important role for a member of staff to fill and the award is just as relevant as the Vet Nurse of the Year or Receptionist of the Year award. The Petplan PIA Award recognises the individual who fully understands and works to help educate clients and staff about insurance, it is also recognises their passion for their role."
To nominate your dedicated PIA for Petplan's PIA of the Year Awards, please visit www.petplan.co.uk/pia. The PIA of the Year will receive a new laptop and their practice will receive £100 in vouchers!
Nominations close on 3rd September and the nominees will be judged by industry professionals. The winner will be announced at the annual BVNA Congress on 9th October.
The company, which until now has only offered loans to practice clients for veterinary treatment, is now offering practice staff loans of £1,000-£25,000 for periods ranging from 1-5 years at an APR from 7.9%, with joint applications acceptable.
Stewart Halperin, BVMS, MRCVS, founder and CEO of CarefreeCredit (pictured right), said: "I first started the company to enable other vets to provide interest-free loans to clients facing large bills for uninsured pets.
"Since then, I’ve been thinking of other ways to help practice staff in our profession and realised a quick and simple low-cost loan facility would be a great way to go beyond helping their clients to helping the staff themselves in their daily lives.
"Now, with just a simple phone call taking just 5 minutes, veterinary staff can easily access the finance they want for whatever purpose they need."
For further information call 0345 313 0177.
The initiative comes after BEVA's new nurse committee ran a survey which found a poor understanding within the profession and amongst clients of what equine nurses can do.
Nurses said they believed they could be given more responsibility and do more within their roles and that there was a lack of opportunity for progression.
BEVA President David Rendle, who is championing this initiative, said: “RVNs are a significant an asset to any equine practice.
“They have invested a lot of time and effort to become highly skilled but in some instances their significant attributes are not being utilised to the full.
“Allowing RVNs to perform the clinical tasks that they are qualified to carry out under Schedule 3 of the Veterinary Surgeons Act 1966, will provide better job fulfilment and career development as well as free up veterinary surgeons to carry out other tasks, all increasing the efficiency of the veterinary team.
“I feel, and the RVN survey results would seem to confirm, that veterinary surgeons and practice managers do not appreciate how much veterinary nurses are allowed to do in equine practice.
"We all know veterinary nurses have the ability; look at what they do in small animal and human nursing, but we have felt unnecessarily constrained by Schedule 3 of the Veterinary Surgeons Act 1966 and the associated RCVS guidelines.
"If you actually look at Schedule 3 it is clear that we can and should be letting our qualified equine nurses do far more.
“There are so many things in equine practice that nurses do better than vets.
"In addition to performing clinical tasks they can add wider value; they are generally (or are perceived by clients to be!) more patient, empathetic and caring so we should utilise these skills and get nurses to take on some of the roles that take more time and require longer client interactions – discussing parasite control programmes, running weight loss clinics, reviewing healthcare plans, making follow-up phone calls and visits to name just a few.
"Nurses can take a lot of pressure off vets and can add a significant revenue stream for the practice.”
On the 9th February, the BEVA will be hosting an online discussion forum for all members of the practice team to discuss the role of nurses and how their skills, experience and knowledge can be better-used.
It's free for BEVA members: https://www.beva.org.uk/Home/Events/BEVA-Events/Event-Details.aspx?eventDateId=1716
Marie Rippingale Chair of the BEVA Nurse Committee said: “Last year’s recruitment and retention survey revealed that 50% of nurse respondents were earning less than £25,000 per annum and 48% of nurses said they were likely to look for a new job in the next two years.
"When asked their top reasons for leaving, salary was the biggest reason, and common themes on what would help the retention of nurses included salary, work-life balance and career progression.
“The review of Schedule 3 is important so we can encourage delegation of tasks to RVNs.
"This will allow RVNs to demonstrate their value and worth, earning money for the practice and achieving job satisfaction at the same time. This will contribute positively towards the current retention crisis.”
To find out more about what equine veterinary nurses can do in practice visit https://www.beva.org.uk/nurses
Photo: Liphook Equine Hospital.
Vetoquinol has announced that the vouchers it provides as part of the Epiphen practice support package for monitoring and management of serum levels of phenobarbital will now be provided directly from the veterinary wholesaler and sent with each order.
One or two vouchers are provided with the 30ml and 60ml packs respectively. The vouchers come complete with a pre-paid envelope in which to send samples directly to the laboratory. Each test is valued at £19.80
For further information, contact your local Vetoquinol Territory Manager.
Henry Schein Inc. has announced an agreement to acquire RxWorks Inc., the veterinary practice management software provider.
Founded in 1988 and with headquarters in Brisbane, Queensland, Australia, RxWorks has 68 team members and an installed base of more than 1,500 veterinary clinics in 19 countries worldwide (primarily Australia, New Zealand, the UK and the Netherlands).
Henry Schein says RxWorks will become part of it's Global Animal Health Practice Solutions business, led by its current management team.
Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, Henry Schein, Inc. said: "RxWorks has an excellent reputation for helping veterinarians increase practice efficiency and improve quality health care through its innovative practice management software solutions.
"The addition of RxWorks further strengthens our growing practice management software solutions business, which helps deepen relationships in the regions served by RxWorks with our animal health customers, including large corporate customers. The addition of RxWorks will nicely complement our expanding animal health technology businesses. We look forward to welcoming our new colleagues from RxWorks to Henry Schein."
Nathan Basha, Chairman of RxWorks said: "RxWorks software is designed to facilitate consistency of patient care, enable practice growth, achieve enhanced profitability and optimize professional time, all the while improving the quality of life for patients. Aligning with Henry Schein, a global company committed to serving animal health professionals and bringing innovation to the marketplace, allows RxWorks to provide even further value to customers while expanding industry reach."
Henry Schein says it expects the acquisition to close in the second half of January 2016. Financial details and terms of the transaction were not disclosed.
CM Research has announced the results of a survey conducted this month in which veterinary surgeons named Osurnia as the best new product of 2015.
290 companion animal veterinary surgeons took part in the survey, which is designed to provide veterinary surgeons with their peers’ unbiased judgement on which new veterinary products, services or devices have made the biggest impact on the industry.
The questions were unprompted to ensure that the respondents were not influenced by pre-set survey options. CM Research points to the fact that many of the products that featured in its rankings were launched before 2015, including 2nd and 3rd placed Apoquel and Bravecto, as evidence of this freedom.
The full list of products named more than once in this year's survey was:
Product
Manufacturer
Number of mentions
% of mentions
Osurnia
Elanco
67
23%
Apoquel
Zoetis
58
20%
Bravecto
MSD
29
10%
Semintra
Boehringer Ingelheim (BI)
13
4%
Amodip
Ceva
10
3%
Nexgard Spectra
Merial
8
Broadline
6
2%
UpCard
Vetoquinol
Zodon
5
Metabolic Diet
Hill's
4
1%
Nexgard
SDMA Test
IDEXX
Comfortis
3
Remend
Bayer
Seresto
Yumove
Lintbells
Bovela
BI
2
Comfortan
Dechra
Hill's y/d diet
Nutraquin
Nutravet
Pexion
Prinovox
Virbac
Pronefra
Thiafeline
Animalcare
Veraflox
Vetigel
Suneris
Cardalis
According to the company, information on best worming strategies for foals and yearlings remains largely anecdotal, making it difficult to develop a clear plan for this age group. Zoetis veterinary surgeon Wendy Talbot has therefore reviewed the recent literature to develop an eight-point plan.
Explaining the guidance, Wendy writes:
Foals and yearlings are usually more susceptible to worms than are adult horses because they have had little chance to develop any immunity. They are more vulnerable to related diseases and tend to have higher egg shedding, which increases the risk of infection. The main parasitic culprits in the UK for foals less than six months of age are large roundworms (ascarids). In older foals and weanlings, small and large strongyles, tapeworms (and pinworms) are the main considerations.1 Yearlings may also have a second wave of large roundworm infection at 8-10 months of age.2 Any control strategy will need to take into account the individual circumstances such as stocking density, pasture management and previous disease history.
Guidelines for parasite control in foals suggest a first treatment with fenbendazole at 2-3 months of age, targeting large roundworm, followed by another treatment at 5-6 months. Alternatively, pyrantel may be considered for these doses; however, there may be resistance in some areas and foals with large adult ascarid burdens may be at higher risk of intestinal rupture when this drug is used.4 At weaning (approximately six months of age), it is advisable to perform a faecal worm egg count (FWEC) to determine if treatment for strongyles is also required; the macrocyclic lactone anthelmintics (ivermectin or moxidectin) are expected to have the highest efficacy. At 9 and 12 months of age treatment for stronglyes and a larvicidal dose for encysted stages of small strongyles (moxidectin or a 5 day course of fenbendazole) are indicated. A tapeworm treatment should be included with one of these doses.2,3
For yearlings, two methods have recently been proposed for worm control: the first involves using faecal worm egg counts (FWECs) at more frequent intervals than for adults to guide dosing for strongyles in the grazing season.1 The second suggests three baseline treatments targeting strongyles in spring, summer and late autumn, with FWECs in between to identify and treat any still shedding high numbers of eggs, up to a maximum of six treatments per year.2 Macrocyclic lactones have the highest expected efficacy against small strongyles and should form the basis of treatments; however, pyrantel can be considered for some treatments where it has been shown to have continued efficacy. Both strategies include a larvcidal treatment for encysted small redworm combined with testing or treating for tapeworm in late autumn. The inclusion of one or two doses of a macrocyclic lactone each year (usually already used for small strongyle control) should be sufficient to prevent large strongyle related disease.3
The wide differences in the circumstances of foals and yearlings, together with geographical variations in resistance patterns and a lack of consensus on best practice in this group means it is not possible to define a single approach to a worming plan. An important point to note is that FWECs may give surprising results because higher counts are generally seen in youngstock.
Eight ways to keep clients' youngstock worms controlled:
For further information on worming together with some equine specific CPD visit: https://blog.vetsupportplus.com/